Expression of the Na+‐d‐Glucose Cotransporter SGLT1 in Neurons
Open accessAbstract
Abstract: In brains of the rabbit, pig, and human, expression of the high‐affinity Na+‐d‐glucose cotransporter SGLT1 and of the protein RS1, which alters the activity of SGLT1, was demonstrated. In situ hybridization showed that SGLT1 and RS1 are transcribed in pyramidal cells of brain cortex and hippocampus and in Purkinje cells of cerebellum. In neurons of pig brain SGLT1 protein was demonstrated by western blotting with synaptosomal membranes and by immunohistochemistry, which showed SGLT1 in pyramidal and Purkinje cells. To test whether SGLT1 in neurons may be activated during increased d‐glucose consumption, an epileptic seizure was induced in rat brain, and the uptake of specific nonmetabolized substrates of SGLT1 {[14 C]methyl‐α‐d‐glucopyranoside ([14 C]AMG)} and of Na+‐independent transporters {2‐deoxy‐d‐[14 C]glucose([14 C]2‐DG)} was analyzed by autoradiography. During the seizure the uptake of AMG and 2‐DG was increased in the focus. Within two hours after the seizure 2‐DG uptake in the focus returned to normal. In contrast, the AMG uptake in the focus area was still increased 1 day later. The data show that the high‐affinity Na+‐d‐glucose cotransporter SGLT1 is expressed in neurons and can be up‐regulated.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
SGLT1 is present in pyramidal cells of the brain cortex, Purkinje cerebellum cells, hippocampus pyramidal and granular cells.
“SGLT1 inhibitors are present in the pyramidal cells of the brain cortex, Purkinje cerebellum cells, hippocampus pyramidal, and granular cells [20].”
From Neuroprotective effect of SGLT2 inhibitors. (2021) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Still being checked.
Research works printed but not linked: 9
- Ne,,rocl,e,,,.. Vol. 69, No. 1, 1997 14714159, 1997, 1, · DOI
- Dick A. P. K., Hank S. I., Klip A., and Walker n. M. (1984) Identi- fication and characterization of the glucose transporter of the blood-brain barrier by cytochalasin B binding and immunolog- ical reactivity. Proc. Nat!. Acaci. Sci. USA 81, 7233-7237.
- Hamprecht B. and Dringen R. (1995) Energy metabolism, in Neuro- glia (Kettenmann H. and Ransom B., eds), pp. 473-487. Ox- ford University Press, New York.
- Hediger M. A.. Turk E., and Wright E. M. (1989) Homology of the human intestinal Na/glucose and E,ccherichia co/i Na' / proline co-transporters. Proc. Nat!. Acad. Sci. USA 86, 5748- 5752.
- Magistretti P. J., Pellcrin L., and Martin J.-L. (1995) Brain energy metaholism-an integrated cellular perspective, in Psycho- pharmacology: The fourth Generation of Pro gre,s.i (Bloom F. F. and Kupf'er D.J.. eds). pp. 657-670. Raven Press, New York.
- Shioda T., Ohta T., tsselhacher K. J., and Rhoads D. B. (1994) Differentiation-dependent expression of the Na ' /glucose co- transporter (SGLTI ) in LLC-PK, cells: role of protein kinase C activation and ongoing transcription. Proc. Nat!. Acad. Sci. USA 91, 11919-11923.
- Siesjo B. K. (1978) Brain Energy Metabolism. Wiley, New York.
- Wilkinson D. G. (1993) The theory and practice olin situ hybridiza- tion, in In Situ Hybridization: A Practical Approach (Wilkinson D. G., ed), pp. 1-13. Oxford University Press, New York.
- Neur,,che,n., Vol. 69, N,i. 1, /997 14714159, 1997, 1, · DOI
Cited by
Sorted by citations
Biology of Human Sodium Glucose Transporters
Wright, E. M., Loo, D. D. F., & Hirayama, B. A. (2011) · Physiological Reviews · doi:10.1152/physrev.00055.2009 · Cited by 1,430 · see citing works
Glucose transporters in brain in health and disease
Koepsell, H. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02441-x · Cited by 558 · see citing works
Self-citationGribble, F. M., Williams, L., Simpson, A. K., & Reimann, F. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1147 · Cited by 394 · see citing works
Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery
Patching, S. (2017) · Molecular Neurobiology · doi:10.1007/s12035-015-9672-6 · Cited by 315 · see citing works
Busch, A. E., Karbach, U., Miska, D., Gorboulev, V., Akhoundova, A., Volk, C., Arndt, P., Ulzheimer, J. C., Sonders, M. S., Baumann, C., et al. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.2.342 · Cited by 333 · see citing works
Self-citationKang, L., Routh, V. H., Kuzhikandathil, E. V., Gaspers, L. D., & Levin, B. E. (2004) · Diabetes · doi:10.2337/diabetes.53.3.549 · Cited by 312 · see citing works
Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members
Chen, J., Williams, S., Ho, S., Loraine, H., Hagan, D. L., Whaley, J. M., & Feder, J. N. (2010) · Diabetes Therapy · doi:10.1007/s13300-010-0006-4 · Cited by 308 · see citing works
A glucose sensor hiding in a family of transporters
Dı́ez-Sampedro, A., Hirayama, B. A., Osswald, C., Gorboulev, V., Baumgarten, K., Volk, C., Wright, E. M., & Koepsell, H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1733027100 · Cited by 308 · see citing works
Self-citationNeuroprotective effect of SGLT2 inhibitors.
Pawlos, A., Broncel, M., Woźniak, E., & Gorzelak-Pabiś, P. (2021) · Molecules · doi:10.3390/molecules26237213 · Cited by 304 · see citing works
Vrhovac, I., Balen, D., Klessen, D., Burger, C., Breljak, D., Kraus, O., Radović, N., Jadrijević, S., Aleksić, I., Walles, T., et al. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1619-7 · Cited by 291 · see citing works
Self-citationKaji, K., Nishimura, N., Seki, K., Sato, S., Saikawa, S., Nakanishi, K., Furukawa, M., Kawaratani, H., Kitade, M., Moriya, K., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31193 · Cited by 244 · see citing works
Glucose Transporters in Brain: In Health and in Alzheimer’s Disease
Szablewski, L. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160841 · Cited by 211 · see citing works
Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus
Song, P., Ōnishi, A., Koepsell, H., & Vallon, V. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1168808 · Cited by 195 · see citing works
Self-citationKoepsell, H. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.10.017 · Cited by 187 · see citing works
Self-citationIdentification of a Novel Na+/myo-Inositol Cotransporter
Coady, M. J., Wallendorff, B., Gagnon, D. G., & Lapointe, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204321200 · Cited by 167 · see citing works
Balen, D., Ljubojević, M., Breljak, D., Brzica, H., Z̆lender, V., Koepsell, H., & Sabolić, I. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00180.2008 · Cited by 166 · see citing works
Self-citationSodium–glucose cotransporters: Functional properties and pharmaceutical potential
Sano, R., Shinozaki, Y., & Ohta, T. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13255 · Cited by 156 · see citing works
Sodium-Coupled Glucose Cotransporters Contribute to Hypothalamic Glucose Sensing
O’Malley, D., Reimann, F. M., Simpson, A. K., & Gribble, F. M. (2006) · Diabetes · doi:10.2337/db06-0531 · Cited by 133 · see citing works
Brain-Derived Neurotrophic Factor Stimulates Energy Metabolism in Developing Cortical Neurons
Burkhalter, J., Fiumelli, H., Allaman, I., Chatton, J., & Martin, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-23-08212.2003 · Cited by 133 · see citing works
Brain Metabolic Alterations in Alzheimer’s Disease
Ardanaz, C. G., Ramírez, M. J., & Solas, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073785 · Cited by 130 · see citing works
Regional distribution of SGLT activity in rat brain in vivo
Yu, A. S., Hirayama, B. A., Timbol, G., Liu, J., Diez-Sampedro, A., Kepe, V., Satyamurthy, N., Huang, S.-C., Wright, E. M., & Barrio, J. R. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00317.2012 · Cited by 126 · see citing works
Romeo, E., Dave, M. H., Bacic, D., Ristic, Z., Camargo, S. M. R., Loffing, J., Wagner, C. A., & Verrey, F. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00286.2005 · Cited by 121 · see citing works
Vemula, S., Roder, K. E., Yang, T., Bhat, G. J., Thekkumkara, T., & Abbruscato, T. J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146589 · Cited by 119 · see citing works
Membrane Localization of the Electrogenic Cation Transporter rOCT1 in Rat Liver
Meyer‐Wentrup, F. A. G., Karbach, U., Gorboulev, V., Arndt, P., & Koepsell, H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9034 · Cited by 112 · see citing works
Self-citationWiciński, M., Wódkiewicz, E., Górski, K. M., Walczak, M., & Malinowski, B. (2020) · Pharmaceuticals · doi:10.3390/ph13110379 · Cited by 110 · see citing works
Abdel-latif, R. G., Rifaai, R. A., & Amin, E. F. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01237-y · Cited by 92 · see citing works
Erdogan, M. A., Yusuf, D., Christy, J., Solmaz, V., Erdogan, A., Taskiran, E., & Erbas, O. (2018) · BMC Neurology · doi:10.1186/s12883-018-1086-4 · Cited by 87 · see citing works
Szablewski, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158142 · Cited by 88 · see citing works
Localization of the Na + -d-glucose cotransporter SGLT1 in the blood-brain barrier
Elfeber, K., K�hler, A., Lutzenburg, M., Osswald, C., Galla, H.-J., Witte, O. W., & Koepsell, H. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0633-9 · Cited by 82 · see citing works
Self-citationVeyhl, M., Wagner, K., Volk, C., Gorboulev, V., Baumgarten, K., Weber, W.-M., Schaper, M., Bertram, B., Wießler, M., & Koepsell, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2914 · Cited by 71 · see citing works
Self-citationChau, J. F. L., Lee, M. K., Law, J. W. S., Chung, S. K., & Chung, S. S. M. (2005) · The FASEB Journal · doi:10.1096/fj.05-4192fje · Cited by 70 · see citing works
Armillotta, M., Angeli, F., Paolisso, P., Belmonte, M., Raschi, E., Dalmazi, G. D., Amicone, S., Canton, L., Fedele, D., Suma, N., et al. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108861 · Cited by 73 · see citing works
Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus
Sim, A. Y., Barua, S., Kim, J. Y., Lee, Y.-H., & Lee, J. E. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.708547 · Cited by 62 · see citing works
Osswald, C., Baumgarten, K., Stümpel, F. T., Gorboulev, V., Akimjanova, M., Knobeloch, K., Horak, I. D., Kluge, R., Joost, H., & Koepsell, H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.78-87.2005 · Cited by 59 · see citing works
Self-citationSGLT2 inhibitors: Beyond glycemic control
Hasan, I., Rashid, T., Jaikaransingh, V., Heilig, C., Abdel‐Rahman, E. M., & Awad, A. S. (2024) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2024.100335 · Cited by 67 · see citing works
Lactate is a critical “sensed” variable in caudal hindbrain monitoring of CNS metabolic stasis
Patil, G. D., & Briski, K. P. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00177.2004 · Cited by 55 · see citing works
Vrhovac, I., Breljak, D., Karaica, D., Koepsell, H., & Sabolić, I. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-2056-1 · Cited by 54 · see citing works
Self-citationSGLT1: A Potential Drug Target for Cardiovascular Disease
Zhao, M., Li, N., & Zhou, H. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s418321 · Cited by 54 · see citing works
Glucose-Sensing in the Reward System
Koekkoek, L. L., Mul, J. D., & la Fleur, S. E. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00716 · Cited by 51 · see citing works
Differential metabolic adaptation to acute and long‐term hypoxia in rat primary cortical astrocytes
Véga, C., Sachleben, L. R., Gozal, D., & Gozal, E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03790.x · Cited by 49 · see citing works
Synthesis of antioxidative and anti-inflammatory drugs glucoconjugates
Uhrig, R. K., Picard, M. A., Beyreuther, K. T., & Wießler, M. (2000) · Carbohydrate Research · doi:10.1016/s0008-6215(99)00311-0 · Cited by 49 · see citing works
Thyroid hormone regulation of the Na+/glucose cotransporter SGLT1 in Caco-2 cells
MATOSIN-MATEKALO, M., Mesonero, J. E., Delézay, O., Poirée, J., Ilundáin, A. A., & Brot‐Laroche, E. (1998) · Biochemical Journal · doi:10.1042/bj3340633 · Cited by 47 · see citing works
RS1 (RSC1A1) regulates the exocytotic pathway of Na+- d -glucose cotransporter SGLT1
Veyhl, M., Keller, T., Gorboulev, V., Vernaleken, A., & Koepsell, H. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00068.2006 · Cited by 47 · see citing works
Self-citationNeuroprotective effects of Canagliflozin: Lessons from aged genetically diverse UM‐HET3 mice
Jayarathne, H. S. M., Debarba, L. K., Jaboro, J. J., Ginsburg, B. C., Miller, R. A., & Sadagurski, M. (2022) · Aging Cell · doi:10.1111/acel.13653 · Cited by 45 · see citing works
Yamazaki, Y., Harada, S., & Tokuyama, S. (2012) · Brain Research · doi:10.1016/j.brainres.2012.10.020 · Cited by 46 · see citing works
Yonamine, C. Y., Michalani, M. L. E., Moreira, R. J., & Machado, U. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216480 · Cited by 50 · see citing works
Oerter, S., Förster, C., & Bohnert, M. (2019) · International Journal of Legal Medicine · doi:10.1007/s00414-018-1893-6 · Cited by 43 · see citing works
Bourgeois, F., Coady, M. J., & Lapointe, J. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.076679 · Cited by 42 · see citing works
The relationship between SGLT2 and systemic blood pressure regulation
Ahwin, P., & Martinez, D. (2024) · Hypertension Research · doi:10.1038/s41440-024-01723-6 · Cited by 41 · see citing works
Acute effects of glucose and insulin on vascular endothelium
Taubert, D., Rosenkranz, A., Berkels, R., Roesen, R., & Sch�mig, E. (2004) · Diabetologia · doi:10.1007/s00125-004-1586-1 · Cited by 37 · see citing works
Jensen, V. F. H., Bøgh, I. B., & Lykkesfeldt, J. (2014) · Journal of Neuroendocrinology · doi:10.1111/jne.12133 · Cited by 37 · see citing works
Yamazaki, Y., Ogihara, S., Harada, S., & Tokuyama, S. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.10.005 · Cited by 35 · see citing works
Zetterling, M., Hillered, L., Enblad, P., Karlsson, T., & Ronne-Engström, E. (2011) · Journal of neurosurgery · doi:10.3171/2011.3.jns10899 · Cited by 34 · see citing works
Repurposing SGLT2 Inhibitors for Neurological Disorders: A Focus on the Autism Spectrum Disorder
Nakhal, M. M., Aburuz, S., Sadek, B. S., & Akour, A. A. (2022) · Molecules · doi:10.3390/molecules27217174 · Cited by 32 · see citing works
Transporter regulator RS1 (RSC1A1) coats thetrans-Golgi network and migrates into the nucleus
Kroiß, M., Leyerer, M., Gorboulev, V., Kühlkamp, T., Kipp, H., & Koepsell, H. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00067.2006 · Cited by 33 · see citing works
Self-citationVernaleken, A., Veyhl, M., Gorboulev, V., Kottra, G., Palm, D., Burckhardt, B. C., Burckhardt, G., Pipkorn, R., Beier, N., van Amsterdam, C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705416200 · Cited by 32 · see citing works
Self-citationHarada, S., Yamazaki, Y., Nishioka, H., & Tokuyama, S. (2013) · Brain Research · doi:10.1016/j.brainres.2013.09.041 · Cited by 31 · see citing works
Modulation of olfactory sensitivity and glucose-sensing by the feeding state in obese Zucker rats
Aimé, P., Palouzier‐Paulignan, B., Salem, R., Koborssy, D. A., Garcia, S., Duchamp, C., Romestaing, C., & Julliard, A. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00326 · Cited by 31 · see citing works
Bormans, G. M., Oosterwyck, G. V., de Groot, T. J., Veyhl, M., Mortelmans, L. A., Verbruggen, A., & Koepsell, H. (2003) · PubMed · Cited by 31 · see citing works
Self-citationKorn, T., Kühlkamp, T., Track, C., Schatz, I., Baumgarten, K., Gorboulev, V., & Koepsell, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105975200 · Cited by 31 · see citing works
Self-citationHutchinson, D. S., Summers, R., & Gibbs, M. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.02.019 · Cited by 33 · see citing works
yanchen, L., Cheng, X., & Dong, Q. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02255-6 · Cited by 29 · see citing works
de Melo, I. S., dos Santos, Y. M. O., Costa, M. A., Pacheco, A. L. D., Silva, N. K. D. G. T., Cardoso-Sousa, L., Pereira, U. P., Goulart, L. R., Garcia‐Cairasco, N., Duzzioni, M., et al. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.05.026 · Cited by 29 · see citing works
Tabatabai, N. M., Blumenthal, S. S., Lewand, D. L., & Petering, D. H. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00201.x · Cited by 28 · see citing works
Sodium-glucose cotransporter 2 inhibitors’ mechanisms of action in heart failure
Rotkvić, P. G., Berković, M. C., Bulj, N., Rotkvić, L., & Ćelap, I. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i7.269 · Cited by 28 · see citing works
Moreira‐Filho, C. A., Bando, S. Y., Bertonha, F. B., Iamashita, P., Silva, F. N., Costa, L. D. F., da Silva, A. V., Castro, L. H. M., & Tzu, W. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128174 · Cited by 25 · see citing works
Sodium–glucose transporter as a novel therapeutic target in disease
Yamazaki, Y., Harada, S., & Tokuyama, S. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.01.003 · Cited by 25 · see citing works
Reinhardt, J., Veyhl, M., Wagner, K., Gambaryan, S. P., Dekel, C., Akhoundova, A., Korn, T., & Koepsell, H. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00250-8 · Cited by 25 · see citing works
Self-citationXie, J., & Guo, Q. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401495200 · Cited by 25 · see citing works
McFadden, S. A., Menchella, J. A., Chalmers, J. A., Centeno, M.-L., & Belsham, D. D. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.035 · Cited by 24 · see citing works
SGLT2 and SGLT1 inhibitors suppress the activities of the RVLM neurons in newborn Wistar rats
Oshima, N., Onimaru, H., Yamashiro, A., Goto, H., Tanoue, K., Fukunaga, T., Sato, H., Uto, A., Matsubara, H., Imakiire, T., et al. (2023) · Hypertension Research · doi:10.1038/s41440-023-01417-5 · Cited by 23 · see citing works
Targeting Glucose Metabolism: A Novel Therapeutic Approach for Parkinson’s Disease
Tanvir, A., Jo, J., & Park, S. M. (2024) · Cells · doi:10.3390/cells13221876 · Cited by 47 · see citing works
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives
Nevola, R., Villani, A., Imbriani, S., Alfano, M., Criscuolo, L., Beccia, D., Ruocco, R., Femine, A. D., Gragnano, F., Cozzolino, D., et al. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2805103 · Cited by 22 · see citing works
Sebastiani, A., Greve, F., Gölz, C., Förster, C. Y., Koepsell, H., & Thal, S. C. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14551 · Cited by 21 · see citing works
Self-citationSLC5 and SLC2 Transporters in Epithelia—Cellular Role and Molecular Mechanisms
Raja, M., Puntheeranurak, T., Hinterdorfer, P., & Kinne, R. K. H. (2012) · Current topics in membranes · doi:10.1016/b978-0-12-394316-3.00002-8 · Cited by 21 · see citing works
Gitau, E., Kokwaro, G. O., Karanja, H., Newton, C. R. J. C., & Ward, S. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit334 · Cited by 21 · see citing works
Fan, X., Chan, O. T. M., Ding, Y., Zhu, W., Mastaitis, J. W., & Sherwin, R. (2015) · Diabetes · doi:10.2337/db15-0022 · Cited by 20 · see citing works
Ishida, N., Saito, M., Sato, S., Tezuka, Y., Sanbe, A., Taira, E., & Hirose, M. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.869 · Cited by 19 · see citing works
Labeled glucose analogs in the genomic era.
Gatley, S. J. (2003) · PubMed · Cited by 20 · see citing works
Yamazaki, Y., Harada, S., Wada, T., Hagiwara, T., Yoshida, S., & Tokuyama, S. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.02.007 · Cited by 19 · see citing works
Cellular and molecular cues of glucose sensing in the rat olfactory bulb
Koborssy, D. A., Palouzier‐Paulignan, B., Salem, R., Thévenet, M., Romestaing, C., & Julliard, A. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00333 · Cited by 19 · see citing works
Valentin, M., Kühlkamp, T., Wagner, K., Krohne, G., Arndt, P., Baumgarten, K., Weber, W.-M., Segal, A., Veyhl, M., & Koepsell, H. (2000) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00277-7 · Cited by 19 · see citing works
Self-citationShim, B., Stokum, J. A., Moyer, M., Tsymbalyuk, N., Tsymbalyuk, O., Keledjian, K. M., Ivanova, S., Tosun, Ç., Gerzanich, V., & Simard, J. M. (2023) · Cells · doi:10.3390/cells12182221 · Cited by 17 · see citing works
Cloning and functional expression of an SGLT-1-like protein from theXenopus laevisintestine
Nagata, K., Hori, N., Sato, K., Ohta, K., Tanaka, H., & Hiji, Y. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.5.g1251 · Cited by 17 · see citing works
Effect of development and hypoxic-ischemia upon rabbit brain glucose transporter expression
Devaskar, S. U., Rajakumar, P. A., Mink, R. B., McKnight, R. A., Thamotharan, S., & Hicks, S. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01143-9 · Cited by 17 · see citing works
Patil, G. D., & Briski, K. P. (2005) · Neuroendocrinology · doi:10.1159/000085522 · Cited by 16 · see citing works
de Melo, I. S., Pacheco, A. L. D., dos Santos, Y. M. O., Figueiredo, L. M., Nicácio, D. C. S. P., Cardoso-Sousa, L., Duzzioni, M., Gitaí, D. L. G., Tilelli, C. Q., Silva, R. S., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02133-8 · Cited by 15 · see citing works
Yamazaki, Y., Arita, K., Harada, S., & Tokuyama, S. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2017.02.016 · Cited by 15 · see citing works
SGLT1 inhibition boon or bane for diabetes‐associated cardiomyopathy
Kalra, J., Mangali, S., Dasari, D., Bhat, A., Goyal, S., Dhar, I., Sriram, D., & Dhar, A. (2019) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12516 · Cited by 14 · see citing works
Ishida, N., Saito, M., Sato, S., Koepsell, H., Taira, E., & Hirose, M. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.134929 · Cited by 13 · see citing works
Self-citationRole of Modulation of Hippocampal Glucose Following Pilocarpine-Induced Status Epilepticus
de Melo, I. S., dos Santos, Y. M. O., Pacheco, A. L. D., Costa, M. A., Silva, V. D. O., Freitas-Santos, J., Cavalcante, C. D. M. B., Silva‐Filho, R., Leite, A. C. R., Gitaí, D. L. G., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02173-0 · Cited by 13 · see citing works
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Harms or Unexpected Benefits?
Andreea, M. M., Surabhi, S., Popescu, R.-I., Ciobotaru, L. M., Nicolae, C., Emil, T., & Tiberiu, N. I. (2023) · Medicina · doi:10.3390/medicina59040742 · Cited by 14 · see citing works
The interplay between sodium/glucose cotransporter type 2 and mitochondrial ionic environment
Borriello, G., Buonincontri, V., Donato, A. D., Corte, M. D., Gravina, I., Iulianiello, P., Joshi, R., Mone, P., Cacciola, G., & Viggiano, D. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101878 · Cited by 12 · see citing works
Metabolism of Mannose in Cultured Primary Rat Neurons
Rastedt, W., Blumrich, E., & Dringen, R. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2241-9 · Cited by 11 · see citing works
Panou, T., Gouveri, E., Popovic, D. S., Papazoglou, D., & Παπάνας, Ν. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01712-z · Cited by 10 · see citing works
Yamazaki, Y., Harada, S., & Tokuyama, S. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.046 · Cited by 10 · see citing works
Brain energetics and glucose transport in metabolic diseases: role in neurodegeneration
Méndez-Flores, O. G., Hernández‐Kelly, L. C., Olivares-Bañuelos, T. N., López‐Ramírez, G., & Ortega, A. (2024) · Nutritional Neuroscience · doi:10.1080/1028415x.2024.2306427 · Cited by 10 · see citing works
Farias, V. X., Uchoa, P. N., Aquino, C. P., Britto, L. R., Fonteles, M. C., Leal‐Cardoso, J. H., da Silva‐Alves, K. S., Havt, A., Prata, M. D. M. G., Heimark, D. B., et al. (2019) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20198589 · Cited by 10 · see citing works
de Groot, T. J., Veyhl, M., Terwinghe, C. Y., Bempt, V. V., Dupont, P. J., Mortelmans, L. A., Verbruggen, A., Bormans, G. M., & Koepsell, H. (2003) · PubMed · Cited by 10 · see citing works
Self-citationDrexler, H. (2002) · doi:10.1290/1071-2690(2002)038
- Authors
- Poppe, R., Karbach, U., Gambaryan, S., Wiesinger, H., Lutzenburg, M., Kraemer, M., Witte, O. W., & Koepsell, H.
- Affiliations
- University of Würzburg (DE)
- University of Tübingen (DE)
- Heinrich Heine University Düsseldorf (DE)
- Corresponding author
- Koepsell, Hermann
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 1997-07
- Volume
- 69
- Issue
- 1
- Pages
- 84-94
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1978754654
- Cited by
- 134
- References
- 0
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 10 · 2023: 10 · 2022: 8 · 2021: 5 · 2020: 8 · 2019: 3 · 2018: 7 · 2017: 6 · 2016: 5 · 2015: 3 · 2014: 5 · 2013: 3 · 2012: 4
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- SGLT1, RS1, neuronal glucose uptake, pyramidal neurons, Purkinje cells, epileptic seizures, cerebral cortex, hippocampus, cerebellum, synaptosomal membranes
- MeSH terms
- Animals, Brain Chemistry, Carbon Radioisotopes, Deoxyglucose, Dogs, Epilepsy, Glucose, Humans, Membrane Glycoproteins, Molecular Sequence Data, Monosaccharide Transport Proteins, Neuroglia, Neurons, Rabbits, Sodium, Swine, Transcription, Genetic, Blotting, Western, Up-Regulation, Gene Expression, In Situ Hybridization, Sequence Analysis, DNA, DNA, Complementary, Sodium-Glucose Transporter 1, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review